CVS Health (NYSE:CVS) Stock Price Down 5.5% – Time to Sell?

CVS Health Co. (NYSE:CVS)’s stock price fell 5.5% during trading on Monday . The stock traded as low as $46.64 and last traded at $46.67. 13,838,306 shares traded hands during trading, an increase of 22% from the average session volume of 11,388,480 shares. The stock had previously closed at $49.37.

Wall Street Analysts Forecast Growth

Several research firms recently commented on CVS. Deutsche Bank Aktiengesellschaft upgraded shares of CVS Health from a “hold” rating to a “buy” rating and set a $66.00 target price on the stock in a research report on Tuesday, December 3rd. Wells Fargo & Company upgraded shares of CVS Health from an “equal weight” rating to an “overweight” rating and lifted their target price for the stock from $60.00 to $66.00 in a research report on Monday, November 18th. Evercore ISI lifted their target price on shares of CVS Health from $62.00 to $75.00 and gave the stock an “outperform” rating in a research report on Tuesday, October 8th. UBS Group lifted their target price on shares of CVS Health from $60.00 to $62.00 and gave the stock a “neutral” rating in a research report on Thursday, November 7th. Finally, Barclays dropped their price target on shares of CVS Health from $75.00 to $71.00 and set an “overweight” rating on the stock in a research report on Thursday, November 7th. One equities research analyst has rated the stock with a sell rating, six have given a hold rating and fourteen have issued a buy rating to the stock. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus price target of $70.50.

CVS Health Stock Up 2.8 %

The firm’s 50 day moving average price is $57.14 and its two-hundred day moving average price is $58.44. The company has a market cap of $56.98 billion, a P/E ratio of 11.49, a price-to-earnings-growth ratio of 0.89 and a beta of 0.54. The company has a debt-to-equity ratio of 0.80, a quick ratio of 0.59 and a current ratio of 0.80.

CVS Health (NYSE:CVS) last released its quarterly earnings data on Wednesday, November 6th. The pharmacy operator reported $1.09 earnings per share for the quarter, beating the consensus estimate of $1.08 by $0.01. The company had revenue of $95.43 billion during the quarter, compared to analyst estimates of $92.72 billion. CVS Health had a net margin of 1.36% and a return on equity of 10.72%. CVS Health’s revenue for the quarter was up 6.3% compared to the same quarter last year. During the same quarter in the previous year, the business posted $2.21 EPS. Equities research analysts anticipate that CVS Health Co. will post 5.32 EPS for the current fiscal year.

CVS Health Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Friday, November 1st. Shareholders of record on Monday, October 21st were paid a dividend of $0.665 per share. The ex-dividend date was Monday, October 21st. This represents a $2.66 dividend on an annualized basis and a yield of 5.87%. CVS Health’s dividend payout ratio (DPR) is presently 67.51%.

Institutional Trading of CVS Health

Hedge funds and other institutional investors have recently bought and sold shares of the business. MidAtlantic Capital Management Inc. bought a new stake in shares of CVS Health in the 3rd quarter worth $25,000. Livelsberger Financial Advisory bought a new stake in shares of CVS Health in the 3rd quarter worth $31,000. Legacy Investment Solutions LLC bought a new stake in shares of CVS Health in the 3rd quarter worth $31,000. Reston Wealth Management LLC bought a new stake in shares of CVS Health in the 3rd quarter worth $32,000. Finally, Kathleen S. Wright Associates Inc. bought a new stake in shares of CVS Health in the 3rd quarter worth $33,000. Institutional investors own 80.66% of the company’s stock.

CVS Health Company Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.